Q4 2011 Earnings Call
August 04, 2011 4:30 pm ET
Brett Sandercock - Chief Financial Officer and Principal Accounting Officer
Peter Farrell - Founder, Executive Chairman, Interim Chief Executive Officer and President
Geoff Neilson - President of Respiratory Care Strategic Business Unit
David Clair - Piper Jaffray Companies
Michael Matson - Mizuho Securities USA Inc.
Craig Collie - Macquarie Research
Ian Abbott - Goldman Sachs & Partners Australia Pty Ltd
David Low - Deutsche Bank AG
Ben Andrew - William Blair & Company L.L.C.
Matthew Prior - BofA Merrill Lynch
Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2011 ResMed Earnings Conference Call. My name is Keisha, and I'll be your operator for today. [Operator Instructions] The company has asked me to address certain matters. First, ResMed does not authorize the recording of any portion of this conference call for any purpose. Second, during the conference call, ResMed may make forward-looking statements such as projections of future revenue or earnings, new product development or new market for the company's products. These statements are made under the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. Risks and uncertainties exist that could cause actual results to materially differ from the forward-looking statements. These factors are discussed in ResMed's SEC filings, such as Forms 10-Q and 10-K, which you may access through the company's website at www.resmed.com.
With that said, I will like to turn the call over to Dr. Peter Farrell, ResMed's Chairman and CEO. Dr. Ferrell, please go ahead, sir.